Meeting of the Uniform Formulary Beneficiary Advisory Panel, 46152 [05-15697]

Download as PDF 46152 Federal Register / Vol. 70, No. 152 / Tuesday, August 9, 2005 / Notices [FR Doc. 05–15673 Filed 8–8–05; 8:45 am] BILLING CODE 5001–06–C DEPARTMENT OF DEFENSE Office of the Secretary Meeting of the Advisory Council on Dependents’ Education Department of Defense Education Activity (DoDEA). ACTION: Open meeting notice. AGENCY: SUMMARY: Pursuant to the Federal Advisory Committee Act, Appendix 2 of title 5, United States Code, Public Law 92–463, notice is hereby given that a meeting of the Advisory Council on Dependents’ Education (ACDE) is scheduled to be held on September 23, 2005, from 8 a.m. to 5 p.m. The meeting will be held at the DoDEA headquarters building at 4040 North Fairfax Drive, Arlington, Virginia 22203. The purpose of the ACDE is to recommend to the Director, DoDEA, general policies for the operation of the Department of Defense Dependents Schools (DoDDS); to provide the Director with information about effective educational programs and practices that should be considered by DoDDS; and to perform other tasks as may be required by the Secretary of Defense. The meeting emphases will be the current operational qualities of schools and the institutionalized school improvement processes, as well as other educational matters. DATES: September 23, 2005, from 8 a.m. to 5 p.m. ADDRESSES: DoDEA headquarters building at 4040 North Fairfax Drive, Arlington, Virginia 22203. FOR FURTHER INFORMATION CONTACT: Mr. Jim Jarrard, at (703) 588–3121 or at James.Jarrard@hq.dodea.edu. Dated: August 2, 2005. Jeannette Owings-Ballard, OSD Federal Register Liasion Officer, Department of Defense. [FR Doc. 05–15668 Filed 8–8–05; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary Joint Advisory Committee on Nuclear Weapons Surety Department of Defense. Notice of Advisory Committee Meeting—Joint Advisory Committee on Nuclear Weapons Surety. AGENCY: ACTION: SUMMARY: The Joint Advisory Committee on Nuclear Weapons Surety VerDate jul<14>2003 15:52 Aug 08, 2005 Jkt 205001 will conduct a closed session on September 8th, 2005 at the Institute for Defense Analyses, Alexandria, VA. The Joint Advisory Committee is charged with advising the Secretaries of Defense and Energy, and the Joint Nuclear Weapons Council on nuclear weapons surety matters. At this meeting the Joint Advisory Committee will receive classified briefings on nuclear weapons safety and security. In accordance with the Federal Advisory Committee Act (Pub. L. 92–463, as amended, Title 5, U.S.C. App. 2, (1988)), this meeting concerns matters sensitive to the interests of national security, listed in 5 U.S.C. Section 552b(c)(1) and accordingly this meeting will be closed to the public. DATES: September 8, 2005. ADDRESSES: Institute for Defense Analyses, 4850 Mark Center Drive, Alexandria, VA 22311–1882. Dated: August 2, 2005. Jeannette Owings-Ballard, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 05–15672 Filed 8–8–05; 8:45 am] BILLING CODE 5001–06–M DEPARTMENT OF DEFENSE Office of the Secretary Meeting of the Uniform Formulary Beneficiary Advisory Panel Department of Defense, Assistant Secretary of Defense (Health Affairs). ACTION: Notice of meeting; Uniform Formulary Beneficiary Advisory Panel. 22041, telephone (703) 681–0064 ext. 3672, fax (703) 681–1242, or e-mail at richard.martel.ctr@tma.osd.mil. The Uniform Formulary Beneficiary Advisory Panel will only review and comment on the development of the Uniform Formulary as reflected in the recommendations of the DoD Pharmacy and Therapeutics (P&T) Committee coming out of that body’s meeting in August 2005. The P&T Committee information and subject matter concerning drug classes reviewed for that meeting are available at https:// pec.ha.osd.mil. Any private citizen is permitted to file a written statement with the advisory panel. Statements must be submitted electronically to richard.martel.ctr@tma.osd.mil no later than September 21, 2005. Any private citizen is permitted to speak at the Beneficiary Advisory Panel meeting, time permitting. One hour will be reserved for public comments, and speaking times will be assigned only to the first twelve citizens to sign up at the meeting, on a first-come, first-served basis. The amount of time allocated to a speaker will not exceed five minutes. SUPPLEMENTARY INFORMATION: Dated: August 3, 2005. Jeannette Owings-Ballard, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 05–15697 Filed 8–5–05; 8:45 am] BILLING CODE 5001–06–P AGENCY: This notice announces a meeting of the Uniform Formulary Beneficiary Advisory Panel. The panel will review and comment on recommendations made to the Director, TRICARE Management Activity, by the Pharmacy and Therapeutics Committee regarding the Uniform Formulary. The meeting will be open to the public. Seating is limited and will be provided only to the first 220 people signing in. All persons must sign in legibly. Notice of this meeting is required under the Federal Advisory Committee Act. DATES: Wednesday, September 28, 2005, from 8 a.m. to 4 p.m. ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: Mr. Rich Martel, TRICARE Management Activity, Pharmacy Operations, Beneficiary Advisory Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA SUMMARY: PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 DEPARTMENT OF DEFENSE Defense Threat Reduction Agency Privacy Act of 1974; System of Records Defense Threat Reduction Agency, DoD. ACTION: Notice to Alter a System of Records; HDTRA 006—Employees Occupational Health Programs. AGENCY: SUMMARY: The Defense Threat Reduction Agency proposes to alter a system of records notice in its existing inventory of records systems subject to the Privacy Act of 1974, (5 U.S.C. 552a), as amended. This proposed action will be effective without further notice on September 8, 2005 unless comments are received which result in a contrary determination. DATES: Send comments to the General Counsel, Defense Threat Reduction Agency, 8725 John J. Kingman Road, Fort Belvoir, VA 22060– 6201. ADDRESSES: E:\FR\FM\09AUN1.SGM 09AUN1

Agencies

[Federal Register Volume 70, Number 152 (Tuesday, August 9, 2005)]
[Notices]
[Page 46152]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-15697]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Department of Defense, Assistant Secretary of Defense (Health 
Affairs).

ACTION: Notice of meeting; Uniform Formulary Beneficiary Advisory 
Panel.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the Uniform Formulary 
Beneficiary Advisory Panel. The panel will review and comment on 
recommendations made to the Director, TRICARE Management Activity, by 
the Pharmacy and Therapeutics Committee regarding the Uniform 
Formulary. The meeting will be open to the public. Seating is limited 
and will be provided only to the first 220 people signing in. All 
persons must sign in legibly. Notice of this meeting is required under 
the Federal Advisory Committee Act.

DATES: Wednesday, September 28, 2005, from 8 a.m. to 4 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Mr. Rich Martel, TRICARE Management 
Activity, Pharmacy Operations, Beneficiary Advisory Panel, Suite 810, 
5111 Leesburg Pike, Falls Church, VA 22041, telephone (703) 681-0064 
ext. 3672, fax (703) 681-1242, or e-mail at 
richard.martel.ctr@tma.osd.mil.

SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory 
Panel will only review and comment on the development of the Uniform 
Formulary as reflected in the recommendations of the DoD Pharmacy and 
Therapeutics (P&T) Committee coming out of that body's meeting in 
August 2005. The P&T Committee information and subject matter 
concerning drug classes reviewed for that meeting are available at 
https://pec.ha.osd.mil. Any private citizen is permitted to file a 
written statement with the advisory panel. Statements must be submitted 
electronically to richard.martel.ctr@tma.osd.mil no later than 
September 21, 2005. Any private citizen is permitted to speak at the 
Beneficiary Advisory Panel meeting, time permitting. One hour will be 
reserved for public comments, and speaking times will be assigned only 
to the first twelve citizens to sign up at the meeting, on a first-
come, first-served basis. The amount of time allocated to a speaker 
will not exceed five minutes.

    Dated: August 3, 2005.
Jeannette Owings-Ballard,
OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 05-15697 Filed 8-5-05; 8:45 am]
BILLING CODE 5001-06-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.